Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.cdtequity.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

Nevilhch Aug. 24 at 5:10 PM

$CDT My usual -10% days are finally back🤑🤑

0 · Reply

ka1954 Aug. 24 at 5:06 PM

$CDT if u wait long enough, people get frustrated and start selling a stock

1 · Reply

Nevilhch Aug. 24 at 2:55 PM

$CDT If you bought those 1,000 shares, you're already losing money,just like with all the other trades you've mentioned, jajajaja😅🤣😅🤣😅. You're a money-losing machine

0 · Reply

ka1954 Aug. 21 at 7:59 PM

$CDT well its under 3 now already. forget next week

0 · Reply

Bears2354 Aug. 21 at 5:02 PM

$CDT hahaha retard alert . My portfolio is up 200 plus percent in the last 3 months hahaha you want me to throw you a bone my little puppy!!! Matter of fact I am going to buy 1000 shares right now in your honor

0 · Reply

BigGreenCandle Aug. 21 at 1:55 PM

$CDT This thing is really being held back. Moon or doom?

0 · Reply

ka1954 Aug. 21 at 1:46 PM

$CDT why do they bother taking this up. this will be down next week yet again below 3

0 · Reply

Sam201 Aug. 21 at 1:44 PM

$CDT hope you loaded!

0 · Reply

BigGreenCandle Aug. 21 at 1:43 PM

$CDT Vapor thin moon shot? Is it finally going to get a move?

0 · Reply

MoneyMacG Aug. 20 at 6:25 PM

$CDT $SVRE $BLRX $NAMI $HKIT prime

0 · Reply

CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion

Jul 20, 2026, 8:30 AM EDT - 5 weeks ago

CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane

2026-07-17T23:55:15.000Z - 5 weeks ago

CDT Equity Inc trading halted, news pending

2026-07-16T12:15:47.000Z - 5 weeks ago

CDT Equity announces 1-for-10 reverse stock split

Jul 16, 2026, 8:00 AM EDT - 5 weeks ago

CDT Equity Inc. Announces Reverse Stock Split

Jun 26, 2026, 8:30 AM EDT - 2 months ago

CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development

2026-06-18T13:07:10.000Z - 2 months ago

CDT Equity notes investment into Sarborg, expansion into quantum computing

Jun 18, 2026, 8:30 AM EDT - 2 months ago

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

Jun 16, 2026, 8:30 AM EDT - 2 months ago

CDT Equity Announces Debt Update and New Loan Facility

2026-05-28T20:47:21.000Z - 3 months ago

CDT Equity receives Nasdaq notice for delayed quarterly report

May 28, 2026, 4:15 PM EDT - 3 months ago

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

2026-05-27T14:17:57.000Z - 3 months ago

CDT Equity granted Canadian patent for AZD5904 in male infertility

AZN

May 27, 2026, 8:00 AM EDT - 3 months ago

CDT Announces Canadian Patent for AZD5904 in Male Infertility

May 7, 2026, 8:30 AM EDT - 3 months ago

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

2026-05-07T04:50:30.000Z - 3 months ago

CDT Equity announces AZD5904 progresses into patent cooperation treaty phase

AZN

May 6, 2026, 8:30 AM EDT - 3 months ago

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

2026-04-27T16:25:54.000Z - 4 months ago

CDT Equity management to meet with Maxim

2026-04-22T10:10:41.000Z - 4 months ago

CDT Equity files to sell 5.35M shares of common stock for holders

2026-04-20T17:25:11.000Z - 4 months ago

CDT Equity management to meet with Maxim

2026-04-16T12:47:10.000Z - 4 months ago

CDT Equity expands multi-pathway value creation strategy across pharma, IP

AZN

Apr 16, 2026, 8:30 AM EDT - 4 months ago

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

Apr 7, 2026, 8:30 AM EDT - 4 months ago

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

2026-03-27T13:45:58.000Z - 5 months ago

CDT Equity Inc trading resumes

2026-03-27T13:35:40.000Z - 5 months ago

CDT Equity Inc trading halted, volatility trading pause

2026-03-26T23:50:31.000Z - 5 months ago

CDT Equity Inc trading halted, news pending

2026-03-26T13:17:06.000Z - 5 months ago

CDT Equity expands Tapinarof intellectual property portfolio with patent filings

Mar 26, 2026, 8:30 AM EDT - 5 months ago

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

2026-03-25T12:27:39.000Z - 5 months ago

CDT Equity announces 1-for-25 reverse stock split

Mar 23, 2026, 8:30 AM EDT - 5 months ago

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

2026-03-18T12:46:14.000Z - 5 months ago

CDT Equity announces stockholders approved all proposals at Special Meeting

Mar 18, 2026, 8:30 AM EDT - 5 months ago

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

2026-03-12T12:36:57.000Z - 5 months ago

CDT Equity notes Sarborg expansion into rare disease signature intelligence

Mar 12, 2026, 8:30 AM EDT - 5 months ago

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

2026-03-05T13:47:10.000Z - 6 months ago

CDT Equity notes Sarborg filing of U.S. provisional patent application

Mar 5, 2026, 8:30 AM EST - 6 months ago

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

2026-03-04T13:38:28.000Z - 6 months ago

CDT Equity says advancing multiple initiatives to enhance shareholder value

AZN

Mar 4, 2026, 8:30 AM EST - 6 months ago

CDT Positions for Transformational Growth

Feb 24, 2026, 8:30 AM EST - 6 months ago

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

Feb 20, 2026, 8:30 AM EST - 6 months ago

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

Jan 2, 2026, 8:30 AM EST - 8 months ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 11 months ago

CDT Equity Increases Bitcoin Holding

Sep 17, 2025, 8:30 AM EDT - 1 year ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 1 year ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Nevilhch Aug. 24 at 5:10 PM

$CDT My usual -10% days are finally back🤑🤑

0 · Reply

ka1954 Aug. 24 at 5:06 PM

$CDT if u wait long enough, people get frustrated and start selling a stock

1 · Reply

Nevilhch Aug. 24 at 2:55 PM

$CDT If you bought those 1,000 shares, you're already losing money,just like with all the other trades you've mentioned, jajajaja😅🤣😅🤣😅. You're a money-losing machine

0 · Reply

ka1954 Aug. 21 at 7:59 PM

$CDT well its under 3 now already. forget next week

0 · Reply

Bears2354 Aug. 21 at 5:02 PM

0 · Reply

BigGreenCandle Aug. 21 at 1:55 PM

$CDT This thing is really being held back. Moon or doom?

0 · Reply

ka1954 Aug. 21 at 1:46 PM

$CDT why do they bother taking this up. this will be down next week yet again below 3

0 · Reply

Sam201 Aug. 21 at 1:44 PM

$CDT hope you loaded!

0 · Reply

BigGreenCandle Aug. 21 at 1:43 PM

$CDT Vapor thin moon shot? Is it finally going to get a move?

0 · Reply

MoneyMacG Aug. 20 at 6:25 PM

$CDT $SVRE $BLRX $NAMI $HKIT prime

0 · Reply

ka1954 Aug. 20 at 4:02 PM

$CDT just fucking kill this already so i can buy it again

1 · Reply

pointnopoint Aug. 20 at 5:03 AM

$CDT

0 · Reply

pointnopoint Aug. 20 at 12:44 AM

$CDT How is this legal/possible? Anyone?

2 · Reply

ka1954 Aug. 19 at 11:22 AM

$CDT another fucking stock that recently did RS went up 1000% PFSA, just like VEEE, WETO, NVVE. come on CDT, do something

0 · Reply

Sam201 Aug. 18 at 3:25 PM

$CDT getting back below 3. Easy swings above n below 3s. but this is riskyy

0 · Reply

Nevilhch Aug. 18 at 1:44 PM

$CDT @Sam201 and @Bears2354 Alright, you assholes, I don't see you promoting anything .Did you blow your accounts already?

0 · Reply

Nevilhch Aug. 18 at 12:16 PM

$CDT very soon 🤑🤑🤑

0 · Reply

ka1954 Aug. 17 at 8:17 PM

$CDT they will fuck this stock badly in coming days. it always happens

0 · Reply

MoneyMacG Aug. 17 at 7:49 PM

$ICCM $AIIO $CDT $RBNE $FABC goodness

0 · Reply

Pennytraderr1 Aug. 17 at 7:05 PM

🚨 $CDT — THIS SETUP IS WILD 👀🔥 💎 ~400K FLOAT (reported estimates) 💰 ~$2M MARKET CAP 🏦 ~$126.7M TOTAL ASSETS 📊 ~$103M STOCKHOLDERS’ EQUITY ⚛️ Sarborg quantum-computing exposure 🧬 Biotech + AI 🔥 NEW Sarborg patent developments 📅 Aug. 28 shareholder meeting = major near-term catalyst

0 · Reply

ka1954 Aug. 14 at 1:56 PM

$CDT they do up 1 day to lure more buyers. no volume

0 · Reply

BigGreenCandle Aug. 13 at 7:04 PM

$CDT Vapor thin float. Has to go sometime. Moon or bust.

1 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A